Reactivation of Herpetic Keratitis in a Patient after Using Two Different Prostaglandin Analogues

Hyun Seung Yang; Ho Gyun Park; Sangkyung Choi

doi:10.3341/jkos.2011.52.9.1119

Journal List > J Korean Ophthalmol Soc > v.52(9) > 1008890

Go to TopGo to Top Go to BottomGo to Bottom

TOOLS

Yang, Park, and Choi: Reactivation of Herpetic Keratitis in a Patient after Using Two Different Prostaglandin Analogues

Original Article

J Korean Ophthalmol Soc 2011;52(9):1119-1122.

Published online: 7 September 2011

DOI: https://doi.org/10.3341/jkos.2011.52.9.1119

Reactivation of Herpetic Keratitis in a Patient after Using Two Different Prostaglandin Analogues

Hyun Seung Yang, MD, Ho Gyun Park, MD, Sangkyung Choi, MD

Department of Ophthalmology, Seoul Veterans Hospital, Seoul, Korea

Address reprint requests to Sangkyung Choi, MD Department of Ophthalmology, Seoul Veterans Hospital #27 Iljasan-gil, Gangdong-gu, Seoul 134-791, Korea Tel: 82-2-2225-1382, Fax: 82-2-2225-1485, E-mail: drskchoi@hanmail.net

Received 3 January 2011 Revised 23 March 2011 Accepted 5 June 2011

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

Abstract

Purpose

To report a case of herpetic keratitis after administration of two different prostaglandin analogues.

Case summary

A 68-year-old female with a history of herpetic keratitis in her right eye after using latanoprost seven years previous presented with redness, mild ocular pain and tearing in the same eye. She had also been prescribed travoprost eye drops for both eyes for uncontrolled glaucoma one month earlier. The cornea in her right eye showed a dendritic epithelial defect with focal epithelial erosions. Travoprost treatment was discontinued, and the herpetic keratitis recovered completely in ten days with acyclovir ointment and oral agent. No further recurrence was observed in the following six months.

Keywords: Herpetic keratitis, Latanoprost, Prostaglandin analogue, Travoprost

References

1. Hong WS, Rhee SW. Clinical observations of herpes keratitis. J Korean Ophthalmol Soc. 1977; 18:129–33.

2. Wand M, Gilbert CM, Liesegang TJ. Latanoprost and herpes simplex keratitis. Am J Ophthalmol. 1999; 127:602–4.

3. Ekatomatis P. Herpes simplex dendritic keratitis after treatment with latanoprost for primary open angle glaucoma. Br J Ophthalmol. 2001; 85:1008–9.

4. Kaufman HE, Varnell ED, Toshida H, et al. Effects of topical unoprostone and latanoprost on acute and recurrent herpetic keratitis in the rabbit. Am J Ophthalmol. 2001; 131:643–6.

5. Camras CB. Latanoprost increases the severity and recurrence of herpetic keratitis in the rabbit; latanoprost and herpes simplex keratitis. Am J Ophthalmol. 2000; 129:271–2.

6. Kaufman HE, Varnell ED, Thompson HW. Latanoprost increases the severity and recurrence of herpetic keratitis in the rabbit. Am J Ophthalmol. 1999; 127:531–6.

7. Kim KE, Moon JI, Chung SK, Baek NH. 3 cases of latanoprost associated herpes simplex keratitis. J Korean Ophthalmol Soc. 2002; 43:1081–5.

8. Kothari MT, Mehta BK, Asher NS, Kothari KJ. Recurrence of bilateral herpes simplex virus keratitis following bimatoprost use. Indian J Ophthalmol. 2006; 54:47–8.

9. Kroll DM, Schuman JS. Reactivation of herpes simplex virus keratitis after initiating bimatoprost treatment for glaucoma. Am J Ophthalmol. 2002; 133:401–3.

10. Villegas VM, Diaz L, Izquierdo NJ. Herpetic keratitis in a patient who used two different prostaglandin analogue ophthalmic solutions: a case report. P R Health Sci J. 2008; 27:348–9.

11. Kaufman HE, Varnell ED, Centifanto YM, Kissling GE. Effect of the herpes simplex virus genome on the response of infection to corticosteroids. Am J Ophthalmol. 1985; 100:114–8.

12. Gordon YJ, Yates KA, Mah FS, Romanowski EG. The effects of Xalatan on the recovery of ocular herpes simplex virus type 1 in the induced reactivation and spontaneous shedding rabbit models. J Ocul pharmacol Ther. 2003; 19:233–45.

Figure 1.

A 68-year-old female with focal epitheliopathy after using travoprost for 4 weeks (first visit).

Figure 2.

Dendritic keratitis in the same patient after using travoprost for 1 month (sencond visit).

TOOLS

Similar articles